Table 2.

Association between carotid plaque and insulin therapy.

	Men		Women		All
	OR (95% CI)	p values	OR (95% CI)	p values	OR (95% CI)	p values
Model 1	1.461 (1.103–1.935)	0.008	1.619 (1.200–2.185)	0.002	1.525 (1.243–1.871)	<0.001
Model 2	1.553 (1.155–2.089)	0.004	1.591 (1.160–2.183)	0.004	1.557 (1.255–1.932)	<0.001
Model 3	1.541 (1.132–2.097)	0.006	1.535 (1.104–2.133)	0.011	1.508 (1.205–1.889)	0.001
Model 4	1.760 (1.234–2.508)	0.002	1.709 (1.179–2.478)	0.005	1.633 (1.237–2.156)	0.001
Model 5	1.867 (1.307–2.666)	0.001	1.810 (1.155–2.837)	0.010	1.695 (1.131–2.196)	<0.001

Model 1: Adjusted for age, DD, hypertension, smoking status, and alcohol use (gender adjustment for all subjects).

Model 2: Further adjustment for use of AHAs, LLDs, APAs, and metformin (gender adjustment for all subjects).

Model 3: Further adjustment for SBP, DBP, BMI, WC, and WHR (gender adjustment for all subjects).

Model 4: Further adjustment for WBC, BPC, ALT, AST, TG, TC, HDL-C, LDL-C, Cr, SUA, UAE, eGFR, CRP, FPG, 2h PPG, HbA1C, FCP, 2h PCP.

Model 5: Further adjustment for Fins and 2h Pins.